Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

40.79

-1.08 (-2.58%)

At close: Aug 13, 2026, 4:00 PM EDT

41.00

+0.21 (0.51%)

After-hours: Aug 13, 2026, 7:34 PM EDT

Rigel Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	276.79	294.28	179.28	116.88	120.24	149.24
Revenue Growth	3.31%	64.15%	53.38%	-2.79%	-19.43%	37.39%
Cost of Revenue	23.84	19.62	18.65	7.11	1.75	1.08
Gross Profit	252.95	274.66	160.63	109.77	118.49	148.15
Selling, General & Admin	122.22	115.9	113.06	105.74	112.45	91.89
Research & Development	43.68	33.3	23.38	24.52	60.27	65.24
Other Operating Expenses	-	-	-	-	1.32	3.52
Total Operating Expenses	165.9	149.2	136.44	130.26	174.04	160.65
Operating Income	87.05	125.47	24.19	-20.49	-55.55	-12.5
Interest Income	4.33	3.68	2.09	2.27	0.68	0.05
Interest Expense	-5.81	-7.32	-7.92	-6.87	-3.71	-4.86
Total Non-Operating Income (Expense)	-1.47	-3.64	-5.83	-4.6	-3.02	-4.81
Pretax Income	85.58	121.83	18.37	-25.09	-58.57	-17.31
Provision for Income Taxes	-236.33	-245.2	0.88	-	-	0.61
Net Income	321.91	367.02	17.49	-25.09	-58.57	-17.91
Net Income to Common	321.91	367.02	17.49	-25.09	-58.57	-17.91
Net Income Growth	229.08%	1999.08%	-	-	-	-
Shares Outstanding (Basic)	18	18	18	17	17	17
Shares Outstanding (Diluted)	20	19	18	17	17	17
Shares Change	8.67%	6.52%	1.64%	2.07%	-0.00%	1.03%
EPS (Basic)	17.67	20.40	0.99	-1.44	-3.44	-1.10
EPS (Diluted)	16.32	19.48	0.99	-1.44	-3.44	-1.10
EPS Growth	201.66%	1867.68%	-	-	-	-
Free Cash Flow	79.4	75.66	31.44	-5.74	-74.21	5.25
Free Cash Flow Growth	20.62%	140.67%	-	-	-	-
Free Cash Flow Per Share	4.06	4.02	1.78	-0.33	-4.35	0.31
Gross Margin	91.39%	93.33%	89.60%	93.92%	98.55%	99.27%
Operating Margin	31.45%	42.63%	13.49%	-17.53%	-46.20%	-8.37%
Profit Margin	116.30%	124.72%	9.75%	-21.47%	-48.71%	-12.00%
FCF Margin	28.69%	25.71%	17.53%	-4.91%	-61.72%	3.52%
EBITDA	89.7	127.88	26.42	-19.25	-54.55	-11.33
EBITDA Margin	32.41%	43.46%	14.74%	-16.47%	-45.37%	-7.59%
EBIT	87.05	125.47	24.19	-20.49	-55.55	-12.5
EBIT Margin	31.45%	42.63%	13.49%	-17.53%	-46.20%	-8.37%
Effective Tax Rate	-276.17%	-201.27%	4.80%	0.00%	0.00%	-3.50%

SEC Filings: 10-K · 10-Q